Positively-charged, porous, polysaccharide nanoparticles loaded with anionic molecules behave as 'stealth' cationic nanocarriers

Pharmaceutical Research

Volumn 27, Issue 1, 2010, Pages 126-133

  Paillard, Archibald ^a   Passirani, Catherine ^a   Saulnier, Patrick ^a   Kroubi, Maya ^b   Garcion, Emmanuel ^a   Benoît, Jean Pierre ^a   Betbeder, Didier ^b,c  

^a UNIVERSITÉ D'ANGERS   (France)

^b UFR3S Pharmacie   (France)

^c UNIVERSITÉ D'ARTOIS   (France)

Author keywords

'soft' electrophoresis; Haemolytic CH50 test; Nanomedicine; Phospholipid; Protein

Indexed keywords

AMMONIUM CHLORIDE; BOVINE SERUM ALBUMIN; DIPALMITOYLPHOSPHATIDYLGLYCEROL; EPICHLOROHYDRIN; GLUCIDEX; GLYCIDYLTRIMETHYLAMMONIUM; LIPOSOME; MALTODEXTRIN; NANOCARRIER; NANOPARTICLE; POLYSACCHARIDE; UNCLASSIFIED DRUG;

ABSORPTION; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; ELECTROPHORETIC MOBILITY; HEMOLYSIS; HUMAN; HYDROPHOBICITY; LIGHT SCATTERING; MOLECULAR WEIGHT; PARTICLE SIZE; POROSITY; PRIORITY JOURNAL; SURFACE PROPERTY; ZETA POTENTIAL;

ANIONS; CATIONS; COMPLEMENT ACTIVATION; DRUG CARRIERS; DRUG COMPOUNDING; ELECTROPHORESIS; HUMANS; MODELS, CHEMICAL; NANOPARTICLES; PARTICLE SIZE; POLYSACCHARIDES; SURFACE PROPERTIES;

EID: 72949109743     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-009-9986-z     Document Type: Article

References (52)

1. M Morille C Passirani A Vonarbourg A Clavreul JP Benoit 2008 Progress in developing cationic vectors for non-viral systemic gene therapy against cancer Biomaterials 29 3477 96 10.1016/j.biomaterials.2008.04.036 18499247
2. DC Drummond CO Noble ME Hayes JW Park DB Kirpotin 2008 Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development J Pharm Sci 97 4696 740 10.1002/jps.21358 18351638
3. SM Moghimi AC Hunter JC Murray 2001 Long-circulating and target-specific nanoparticles: theory to practice Pharmacol Rev 53 283 318 11356986
4. Passirani C, Benoit JP. Complement activation by injectable colloidal drug carriers. In: Mahato RI, editor. Biomaterials for delivery and targeting of proteins and nucleic acids. New York: CRC; 2005. p. 187-230.
5. HJ Muller-Eberhard 1988 Molecular organization and function of the complement system Annu Rev Biochem 57 321 47 10.1146/annurev.bi.57.070188.001541 3052276
6. Mayer M. Complement and complement fixation. In: Kabat EA, Mayer MM, editors. Experimental immunochemistry. 2nd ed. Springfield: Thomas; 1961. p. 133-56.
7. Kazatchkine M, Hauptmann G, Nydegger U. Techniques du Complement. Livre ed.INSERM collection technique en immunologie. 1986;22-33.
8. AL Klibanov K Maruyama VP Torchilin L Huang 1990 Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes FEBS Lett 268 235 7 10.1016/0014-5793(90)81016-H 2384160 (Pubitemid 20233874)
9. TM Allen A Chonn 1987 Large unilamellar liposomes with low uptake into the reticuloendothelial system FEBS Lett 223 42 6 10.1016/0014-5793(87)80506-9 3666140
10. A Gabizon R Isacson E Libson B Kaufman B Uziely R Catane CG Ben-Dor E Rabello Y Cass T Peretz A Sulkes R Chisin Y Barenholz 1994 Clinical studies of liposome-encapsulated doxorubicin Acta Oncol 33 779 86 10.3109/02841869409083948 7993646
11. H Maeda J Wu T Sawa Y Matsumura K Hori 2000 Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J Control Release 65 271 84 10.1016/S0168-3659(99)00248-5 10699287 (Pubitemid 30122932)
12. Y Matsumura H Maeda 1986 A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res 46 6387 92 2946403
13. A Vonarbourg C Passirani P Saulnier P Simard JC Leroux JP Benoit 2006 Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake J Biomed Mater Res A 78 620 8 16779767
14. Y Jallouli A Paillard J Chang E Sevin D Betbeder 2007 Influence of surface charge and inner composition of porous nanoparticles to cross blood-brain barrier in vitro Int J Pharm 344 103 9 10.1016/j.ijpharm.2007.06.023 17651930 (Pubitemid 47495981)
15. PM Loiseau L Imbertie C Bories D Betbeder I De Miguel 2002 Design and antileishmanial activity of amphotericin B-loaded stable ionic amphiphile biovector formulations Antimicrob Agents Chemother 46 1597 601 10.1128/AAC.46.5.1597-1601.2002 11959611 (Pubitemid 34415357)
16. A Debin R Kravtzoff JV Santiago L Cazales S Sperandio K Melber Z Janowicz D Betbeder M Moynier 2002 Intranasal immunization with recombinant antigens associated with new cationic particles induces strong mucosal as well as systemic antibody and CTL responses Vaccine 20 2752 63 10.1016/S0264-410X(02) 00191-3 12034102 (Pubitemid 34601001)
17. S Elmir A Casanova D Betbeder F Triebel 2001 A combination of interleukin-2 and 60 nm cationic supramolecular biovectors for the treatment of established tumours by subcutaneous or intranasal administration Eur J Cancer 37 1053 60 10.1016/S0959-8049(01)00084-3 11334732 (Pubitemid 32397692)
18. BC Baudner O Balland MM Giuliani P Von Hoegen R Rappuoli D Betbeder G Del Giudice 2002 Enhancement of protective efficacy following intranasal immunization with vaccine plus a nontoxic LTK63 mutant delivered with nanoparticles Infect Immun 70 4785 90 10.1128/IAI.70.9.4785-4790.2002 12183520 (Pubitemid 34907284)
19. D Betbeder S Sperandio JP Latapie J de Nadai A Etienne JM Zajac B Frances 2000 Biovector nanoparticles improve antinociceptive efficacy of nasal morphine Pharm Res 17 743 8 10.1023/A:1007594602449 10955851 (Pubitemid 30670641)
20. A Razafindratsita N Saint-Lu L Mascarell N Berjont T Bardon D Betbeder L Van Overtvelt P Moingeon 2007 Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation J Allergy Clin Immunol 120 278 85 10.1016/j.jaci.2007.04.009 17531296 (Pubitemid 47411528)
21. L Fenart A Casanova B Dehouck C Duhem S Slupek R Cecchelli D Betbeder 1999 Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier J Pharmacol Exp Ther 291 1017 22 10565819
22. M Major E Prieur JF Tocanne D Betbeder AM Sautereau 1997 Characterization and phase behaviour of phospholipid bilayers adsorbed on spherical polysaccharidic nanoparticles Biochim Biophys Acta 1327 32 40 10.1016/S0005-2736(97)00041-2 9247164 (Pubitemid 27283396)
23. MC Woodle D Papahadjopoulos 1989 Liposome preparation and size characterization Methods Enzymol 171 193 217 10.1016/S0076-6879(89)71012-0 2593841 (Pubitemid 20010200)
24. JP Siguier M Major O Balland 2002 Development of a new method to characterize (SMBV) antigen formulations using surface plasmon resonance technology Int J Pharm 242 411 5 10.1016/S0378-5173(02)00227-2 12176290 (Pubitemid 34899499)
25. MM Domingues PS Santiago MARB Castanho NC Santos 2008 What can light scattering spectroscopy do for membrane-active peptide studies? J Pept Sci 14 394 400 10.1002/psc.1007 18189339 (Pubitemid 351540897)
26. E Serefoglou J Oberdisse G Staikos 2007 Characterization of the soluble nanoparticles formed through coulombic interaction of bovine serum albumin with anionic graft copolymers at low pH Biomacromolecules 8 1195 9 10.1021/bm061094t 17315925 (Pubitemid 46672698)
27. H Ohshima 2007 Electrokinetics of soft particles Colloid Polym Sci 285 1411 21 10.1007/s00396-007-1740-7 (Pubitemid 350182502)
28. A Vonarbourg P Saulnier C Passirani JP Benoit 2005 Electrokinetic properties of noncharged lipid nanocapsules: influence of the dipolar distribution at the interface Electrophoresis 26 2066 75 10.1002/elps.200410145 15852355 (Pubitemid 40852638)
29. K Matsuzaki M Harada S Funakoshi N Fujii K Miyajima 1991 Physicochemical determinants for the interactions of magainins 1 and 2 with acidic lipid bilayers Biochim Biophys Acta 1063 162 70 10.1016/0005-2736(91)90366-G 2015255
30. I De Miguel L Imbertie V Rieumajou M Major R Kravtzoff D Betbeder 2000 Proofs of the structure of lipid coated nanoparticles (SMBV) used as drug carriers Pharm Res 17 817 24 10.1023/A:1007504124603 10990200 (Pubitemid 30666962)
31. H Ohshima 1994 Electrophoretic mobility of soft particles J Colloid Interface Sci 163 474 83 10.1006/jcis.1994.1126
32. V Ducel P Saulnier J Richard F Boury 2005 Plant protein-polysaccharide interactions in solutions: application of soft particle analysis and light scattering measurements Colloids Surf B Biointerfaces 41 95 102 10.1016/j.colsurfb.2004.10.031 15737533 (Pubitemid 40298821)
33. K Makino N Yamamoto K Higuchi N Harada H Ohshima H Terada 2003 Phagocytic uptake of polystyrene microspheres by alveolar macrophages: effects of the size and surface properties of the microspheres Colloids Surf B Biointerfaces 27 33 9 10.1016/S0927-7765(02)00042-5 (Pubitemid 35346319)
34. K Makino M Umetsu Y Goto A Nakayama T Suhara J Tsujii A Kikuchi H Ohshima Y Sakurai T Okano 1999 Interaction between charged soft microcapsules and red blood cells: effects of PEGylation of microcapsule membranes upon their surface properties Colloids Surf B Biointerfaces 13 287 97 10.1016/S0927-7765(99)00041-7 (Pubitemid 29281556)
35. A Beduneau P Saulnier N Anton F Hindre C Passirani H Rajerison N Noiret JP Benoit 2006 Pegylated nanocapsules produced by an organic solvent-free method: Evaluation of their stealth properties Pharm Res 23 2190 9 10.1007/s11095-006-9061-y 16952009
36. D Labarre B Montdargent M Carreno F Maillet 1993 Strategy for in vitro evaluation of the interactions between biomaterials and complement system J Appl Biomater 4 231 40 10.1002/jab.770040304
37. C Passirani G Barratt JP Devissaguet D Labarre 1998 Long-circulating nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) Pharm Res 15 1046 50 10.1023/A:1011930127562 9688058 (Pubitemid 28356921)
38. M Roser D Fischer T Kissel 1998 Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats Eur J Pharm Biopharm 46 255 63 10.1016/S0939- 6411(98)00038-1 9885296 (Pubitemid 29057671)
39. A Vonarbourg C Passirani P Saulnier JP Benoit 2006 Parameters influencing the stealthiness of colloidal drug delivery systems Biomaterials 27 4356 73 10.1016/j.biomaterials.2006.03.039 16650890 (Pubitemid 43674179)
40. CD Black G Gregoriadis 1976 Interaction of liposomes with blood plasma proteins Biochem Soc Trans 4 253 6 63397
41. J Toufik D Labarre 1995 Relationship between reduction of complement activation by polysaccharide surfaces bearing diethylaminoethyl groups and their degree of substitution Biomaterials 16 1081 8 10.1016/0142-9612(95)98904-S 8519929
42. MP Carreno D Labarre M Jozefowicz MD Kazatchkine 1988 The ability of Sephadex to activate human complement is suppressed in specifically substituted functional Sephadex derivatives Mol Immunol 25 165 71 10.1016/0161-5890(88) 90064-8 2453793 (Pubitemid 18197492)
43. SK Law TM Minich RP Levine 1981 Binding reaction between the third human complement protein and small molecules Biochemistry 20 7457 63 10.1021/bi00529a020 7326238
44. D Labarre A Laurent A Lautier S Bouhni L Kerbellec JM Lewest N Tersinet 2002 Complement activation by substituted polyacrylamide hydrogels for embolisation and implantation Biomaterials 23 2319 27 10.1016/S0142-9612(01) 00366-0 12013179 (Pubitemid 34234833)
45. DE Owens 3rd NA Peppas 2006 Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles Int J Pharm 307 93 102 10.1016/j.ijpharm.2005.10.010 16303268 (Pubitemid 41773257)
46. A Gabizon D Papahadjopoulos 1992 The role of surface charge and hydrophilic groups on liposome clearance in vivo Biochim Biophys Acta 1103 94 100 10.1016/0005-2736(92)90061-P 1309663
47. CL Villiers MB Villiers PN Marche 1999 Role of the complement C3 protein in the control of the specific immune response Ann Biol Clin (Paris) 57 127 35
48. A Aqil S Vasseur E Duguet C Passirani JP Benoît A Roch R Müller R Jérôme C Jérôme 2008 PEO coated magnetic nanoparticles for biomedical application Eur Polymer J 44 3191 9 10.1016/j.eurpolymj.2008.07.011
49. KV Butsele S Cajot SV Vlierberghe P Dubruel C Passirani J-P Benoit R Jérôme C Jérôme 2009 pH-responsive flower-type micelles formed by a biotinylated poly(2-vinylpyridine)-block-poly(ethylene oxide)-block-poly(E-caprolactone) triblock copolymer Adv Func Mater 19 1416 25 10.1002/adfm.200801117
50. K Van Butsele P Sibret CA Fustin JF Gohy C Passirani JP Benoit R Jerome C Jerome 2009 Synthesis and pH-dependent micellization of diblock copolymer mixtures J Colloid Interface Sci 329 235 43 10.1016/j.jcis.2008.09.080 18930246
51. A Layre P Couvreur H Chacun J Richard C Passirani D Requier JP Benoit R Gref 2006 Novel composite core-shell nanoparticles as busulfan carriers J Control Release 111 271 80 10.1016/j.jconrel.2006.01.002 16488504
52. J Rieger C Passirani J-P Benoit K Van Butsele R Jérôme C Jérôme 2006 Synthesis of amphiphilic copolymers of poly(ethylene oxide) and poly(&egr;-caprolactone) with different architectures, and their role in the preparation of stealthy nanoparticles Adv Funct Mater 16 1506 14 10.1002/adfm.200500110 (Pubitemid 44117339)